The Next Phase For Regenerative Medicine: New Advocacy Group To Focus On Regulatory, Reimbursement Policy
This article was originally published in The Pink Sheet Daily
Executive Summary
Association combines venture capital and political capital to help assure that new stem cell policy does more than produce science for science's sake.